Cardiothoracic Surgery Norwegian register for general thoracic surgery Steinar Solberg MD PhD Department of Cardiothoracic Surgery Rikshospitalet Norway ssolberonlineno ID: 921221
Download Presentation The PPT/PDF document "Norwegian Association for" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Norwegian Association for
Cardiothoracic Surgery
Norwegian register for general thoracic surgery.Steinar Solberg, MD, PhD.Department of Cardiothoracic SurgeryRikshospitalet, Norwayssolber@online.no
Thoracic surgery in Norway 2019
Slide2Summary, 2019A high number – total 1562 operations and 748 operations for lung cancer are reported.
A higher proportion of females (34.8 %) than males (28.1 %) are operated by thoracoscopy for lung cancer (p=0.000). The proportion of lung cancer operations has increased steadily from 37.0 % in 2010 to 47.9 % of the total numbers of operations in 2019.
The female predominance in surgery for lung cancer increased from 53 % in 2018 to 56 % in 2019.Robotic surgery is offered at AHUS, Haukeland and in Tromsø.Two hospitals have a low number lung cancer operations.Norwegian Association for Cardiothoracic Surgery
Slide3Outstandingly low mortality in surgery for lung cancer.30 days mortality: 0.6 % (four deaths in 718 operations)A high proportion (22 %) of lung cancer patients are operated. In addition 7 % are treated with stereotactic radiation and 8 % with fractioned radiation. Thus 37 % are treated with intention to cure.In surgery, 49.5 % are operated by minimally invasive technique (thoracoscopy or robot). This varies from 0 to 85.7 % between the hospitals. Three hospitals has a too low (< 40 %) proportion of the operations performed mini invasively.
The 5 year relative survival in those operated is high (65.0 %) and varies from 57.8 % to 72.2 % between the hospitals.Practically all (99.9 %) of the operations are reported, but in too many hospitals the reports are send very late – up to median 286 days after surgery. Such delay may jeopardise the quality of the data.The removal of lymph nodes in surgery is disappointingly low.
Synopsis from
The Cancer Registry of Norway, 2019
Slide4The quality of lung cancer surgery is very high. Though, some improvements may be suggested: Three hospitals should increase the use of minimally invasive technique.
The time from surgery to reporting to The Cancer Registry should be reduced markedly by several hospitals.More lymph node stations should be operated out.All hospitals should meet the criteria set by the national health authorities.
Norwegian Association for Cardiothoracic Surgery
Slide5Norwegian Association for Cardiothoracic Surgery
Number
of general thoracic operations reported
Slide6Norwegian Association for
Cardiothoracic
Surgery
Number of operations per hospital per year
Slide7Norwegian Association for Cardiothoracic Surgery
Accesses used
Slide8Norwegian Association for Cardiothoracic Surgery
Underlying diagnoses
Slide9Norwegian Association for Cardiothoracic Surgery
Organ operated upon
Slide10Norwegian Association for Cardiothoracic Surgery
Selected
operations performed
Slide11Norwegian Association for Cardiothoracic Surgery
Number of operations for lung metastases performed annually
Slide12Norwegian Association for
Cardiothoracic
Surgery
Operations for lung cancer*
The Cancer
Registry
has
registerted
718
operations
in 2019
*
Slide13Norwegian Association for
Cardiothoracic
Surgery
Number of operations for lung cancer per hospital per year
Slide14Norwegian Association for Cardiothoracic Surgery
Prosedures performed in operations for lung cancer
Slide15Norwegian Association for Cardiothoracic Surgery
The
number
(bars) and percentage (line) of operationsfor lung cancer performed by VATS or RATS (robot)43 operations
performed
by RATS in 2019
Slide16Norwegian Association for Cardiothoracic Surgery
Operations for
lung
cancer performed by robot
Slide17From
the
Cancer Registry of Norway, 2019
Figure 3.13The percentage of resections for lung cancer performed bythoracoscopy (VATS) and byRobot assisted thoracic surgery
(RATS)
Slide18Norwegian Association for Cardiothoracic Surgery
The
percentage
of patiens beeing females in surgery for lung cancer
Slide19Norwegian Association for Cardiothoracic Surgery
Per cent
operated
for lung cancerby thoracoscopy 2010 - 2019 (n=6377)
*
Difference
between
the
sexes
: p = 0.000 (Pearson chi2)
*
Slide20Norwegian Association for Cardiothoracic Surgery
The number (bars) and percentage (line) of patients
operated for lung cancer being 80 years or older
Slide21Norwegian Association for Cardiothoracic Surgery
The number
of operation for lung cancer as proportion
of the total number of operations in general thoracic surgery
Slide22http://www.kreftregisteret.no/
The Cancer
Registry
of Norway Figure 3.15Five year relative survival after surgery 2015-2019.
Slide23Figure 1.1
The indicators for quality for the treatment and the reporting to The Cancer Registry.
From The Cancer Registry
of Norway, 2019
Slide24Figure 3.19
One and five year relative survival for all patients diagnosed with lung cancer per year.
From
The Cancer Registry of Norway, 2019
Slide25Figure 3.20
The median survival (in months) for all patients diagnosed with lung cancer per year.
From
The Cancer Registry of Norway, 2019
Slide26From The Cancer Registry
of
Norway, 2019
Figure 5.4The proportion of the operations that are reported and the median time (in days) from surgery to reporting.
Slide27From The Cancer Registry
of
Norway, 2019
Figure 1.2 The “flow” for patients operated for lung cancer in 2019. From left: the 1-year relative survival for all patients with lung cancer in the respective hospital areas, the proportion operated, the flow from local hospitals to hospitals performing the surgery, the 30 days mortality and 1-year relative survival for those operated.
Slide28Figure
3.12
The mean number of lymph nodes reported removed in surgery – either by «biopsy from nodes», «removal of hole lumph nodes» og by «complete removal
of lymph node stations».
From T
he
Cancer
Registry
of
Norway,
2019
Slide29Figure
3.9
The proportion of the patients given curative treatmet – surgery, stereotactic radiation or fractionated radiotherapy.
From The Cancer Registry of
Norway,
2019
Slide30Figure
3.14
. 30 days mortality after surgery for lung cancer
From The Cancer Registry of Norway, 2019
Slide31T H A N K Y O U